Background information › PTEN (function, connection with breast cancer) Objective Experimental Approach and Results Conclusion Future research
PTEN (phosphatase and tensin homolog) Function: tumor supression (regulate cell cycle and apoptosis) Mutant forms shown to be involved in breast cancer Courtesy of
Cowden Syndrome (CS) › Greater risk of breast cancer (25-50%; 13% for general population) › Earlier age of onset › Caused by mutations in PTEN PTEN with mutation in ATP-binding motif › PTEN K62R, PTEN Y65C, and PTEN K125E › Cause mislocalization in the nucleus
Researchers sought to analyze the functional consequences of nuclear-cytoplasmic mislocalization of these PTEN ATP-binding mutants, and whether these consequences may induce breast carcinogenesis.
Effects on cell cycle regulation pathways Effects on p53 levels Amount of double stranded breaks (DSBs) Levels of reactive oxygen species (ROS) Effects on antioxidant activity
Purpose: Determine the effects of increased levels of PTEN on cell cycle regulation pathways Method: immunoblotting › P-AKT: cell cycle arrest, lipid phosphatase › Cyclin D1: G1/S checkpoint
Only wild type is able to decrease levels of P-AKT and cyclin D1
Test 1 Purpose: Determine effect of overexpression of ATP-binding mutants on apoptosis and G1/S cell ratio Method: Subcellular fractionation of MCF-7 cells (human breast carcinoma line) › p53: induces apoptosis
Nuclear p53 level decreases in mutant
Test 2 Purpose: Reconfirm results of test 1 Method: same cells were examined using immunofluorescence confocal analyses to determine p53 levels
DAPI used to stain nucleus 85% increase in staining intensity in wild type Mutants have decreased intensity
Test 2, continued Purpose: Determine whether p53 is translated in ATP-binding mutants Method: Add proteasome inhibitor and use immunofluorescence confocal analyses
Test 3 Purpose: Investigate mechanism of p53 degradation Method: observed level of MDM2 and phospho-MDM2 in MCF-7 cells using immunoblotting
High levels of MDM2 and P- MDM2 in wild type PTEN Low levels in ATP-binding mutants
Purpose: Test DNA for double-stranded breaks (DSBs) Method: senile cells were treated with histone H2AX, which binds to broken DNA. DSBs were then detected using immunofluorescence microscopy
DAPI stains nucleus γ -H2AX is phosphoylated form of histone H2AX which signals DSBs
Test 1 Purpose: Examine basal levels of reactive oxygen species (ROS) production in cancer cells Method: immunofluorescence
Hoechst used to stain DNA DCF represents ROS Reduced ROS level in wild type Increased ROS level in mutant
Test 2 Purpose: Compare mRNA levels of tumor protein 53-induced nuclear protein (TP53INP), which mediates p53 antioxidant function Method: qRT-PCR
mRNA level reduced in PTEN mutants Suggests reduced p53 antioxidant activity
Test 3 Purpose: Compare quantities of SOD1, a superoxide dismutase (an antioxidative enzyme) Method: Western Blot
Increased levels in mutant cells Researchers conclude that mutation leads to increased levels, but aberrant expression
PTEN ATP-binding mutants have a reduced ability to regulate cell cycle, as evidenced by P-AKT and cyclin D levels Mutation reduces nuclear p53 levels through a MDM2 independent mechanism › Researchers speculate that this is due to an inability to bind to p300 and stabilize p53 through acetylation Mutant cells show increased levels of ROS, leading to oxidative stress. › May lead to DSBs › Important role in breast tumorigenesis
Determine mechanism by which mutation increases frequency of DSBs Determine mechanism by which p53 is degraded in mutant cells Research mechanism by which oxidative stress is increased in cells